Alopecia Areata (AA) | Pedestal Health

6

Total Publications

1

Oral Presentation

5

Poster Presentation

2026 · Poster Presentation · Poster Presentation · Dermatology

The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM.

2025 · Poster Presentation · Maui Derm Conference · Dermatology

Correlation between achieving SALT 20 score and clinician- and patient-reported outcomes among patients diagnosed with alopecia areata in the US: An assessment from the TARGET-DERM AA registry.

2025 · Poster Presentation · Poster Presentation · Dermatology

Race and ethnicity sub-groups of alopecia areata patients have differing clinical characteristics: TARGET-DERM AA.

2025 · Poster Presentation · Poster Presentation · Dermatology

Generic vs. disease-specific patient reported outcome (PRO) instruments for assessing HRQoL burden among patients diagnosed with alopecia areata: Evidence from TARGET-DERM AA.

2024 · Poster Presentation · Poster Presentation · Dermatology

Demographics and disease characteristics of patients with alopecia areata with comorbid atopic dermatitis, vitiligo or anxiety/depression: TARGET-DERM AA.

2024 · Oral Presentation · AAD Annual Meeting · Dermatology

Patient reported burden is associated with clinician-reported severity in alopecia areata: Real world insights from TARGET-DERM AA.

News — Patient-Reported Outcomes Data from Longest Running Dermatology Study: TARGET-DE | Grid

Patient-Reported Outcomes Data from Longest Running Dermatology Study: TARGET-DERM AA Poster Presented at American Academy of Dermatology (AAD) 2024